ABK Biomedical

Halifax, Canada · Founded 2012 · Privately Held (backing)

Developer of a microsphere product designed to improve the treatment of hypervascular tumors. ABK Biomedical is based in Halifax, Canada and was founded in 2012. Its last reported valuation was $73 million in Dec 2022. It has raised $122 million across 4 recorded rounds; the latest was a $2.6 million seed round in Oct 2025.

Last reported valuation
$73.0M
Oct 2026
Priced at
—
Total raised
$121.7M
Last round
Seed Round
Oct 2025
What is ABK Biomedical worth?
$73.0Mlast reported valuation · Oct 2026

ABK Biomedical's last reported valuation, Dec 2022. Nothing priced has surfaced since.

Free account
More of ABK Biomedical with a free account
  • ·The complete investor list: 11 names
  • ·Watch ABK Biomedical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

ABK Biomedical funding history

4 rounds
DateRoundRaisedPost-money
Oct 2025Seed Round$2.6M▮
Apr 2025Early Stage VC$26.1M▮
Sep 2022Early Stage VC$28.5M▮
Apr 2019Early Stage VC$23.5M▮
Unlock post-money valuations

Membership and data by Private Market View

ABK Biomedical valuation

ABK Biomedical's last reported valuation was $73 million in Dec 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has ABK Biomedical raised?

ABK Biomedical has raised $122 million across 4 recorded rounds since 2019. The largest was a $28.5 million early-stage round in Sep 2022; the most recent was a $2.6 million seed round in Oct 2025.

ABK Biomedical has filed 4 Form Ds with the SEC since 2019, most recently in May 2025 ($26.1 million sold to 24 investors).

How ABK Biomedical's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For ABK Biomedical, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about ABK Biomedical

What is ABK Biomedical worth?
ABK Biomedical is valued at $73.0M as of Oct 2026. ABK Biomedical's last reported valuation, Dec 2022. Nothing priced has surfaced since.
How much has ABK Biomedical raised?
ABK Biomedical has raised $121.7M in total funding across 4 recorded rounds.
When did ABK Biomedical last raise?
ABK Biomedical last raised in Oct 2025 (Seed Round), raising $2.6M.